VK Sharma of HDFC Securities told CNBC-TV18, "Reliance Capital is fundamentally better placed and the valuations are very attractive. Technically and derivative wise the stock has now moved up. I am suggesting to buy in Reliance Capital the 450 Call at around Rs 20, keep stop loss at Rs 16 with a target of around Rs 27. This has a long way to go and this is our pick for the current series." "Sun Pharmaceutical Industries is an opportunity which is 31 percent down from its all time high at a time when the Nifty itself is merely 5 percent down from 9,130. I am suggesting to buy the 840 Call here at Rs 23 with stop loss at Rs 17 and a target at around 35," he said. "Mahindra & Mahindra Financial Services is a company which doesn't produce good results. However, those results have now been digested. Some position has been built long in terms of 4 percent of open interest going up. I am buying the 330 Call at Rs 9 with stop loss at Rs 6 and target around Rs 15 which I think should come up in the series," he added.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
